China SXT Pharmaceuticals Inc (SXTC) — Cash Flow Reinvestment Rate
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting $25.28K (capex $25.28K ) from operating cash flow of $234.18K. Check earnings quality score of China SXT Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China SXT Pharmaceuticals Inc Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for China SXT Pharmaceuticals Inc across 6 annual periods. Explore China SXT Pharmaceuticals Inc (SXTC) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for China SXT Pharmaceuticals Inc (2016–2022)
Year-by-year capital reinvestment analysis for China SXT Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of China SXT Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.41x | $109.40K | $268.29K | $62.49K | ▼ -93.5% |
| 2020 | 6.32x | $5.90 Million | $934.25K | $406.66K | ▲ +23.9% |
| 2019 | 5.10x | $1.22 Million | $239.19K | $610.09K | ▲ +346.5% |
| 2018 | 1.14x | $2.19 Million | $1.92 Million | $1.05 Million | ▼ -91.1% |
| 2017 | 12.89x | $3.78 Million | $293.04K | $186.31K | ▲ +2324.4% |
| 2016 | 0.53x | $96.99K | $182.47K | $96.99K | — |